Cargando…

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †

Galectin-3 is demonstrated to be a robust independent marker of cardiovascular mid-term (18-month) outcomes in heart failure (HF) patients. The aim of this study was to analyze the value of a pre-discharged determination of galectin-3 alone and with brain natriuretic peptide (BNP) in predicting mid-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Marzia, Rosso, Gian Luca, Ferreri, Cinzia, Feola, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313508/ https://www.ncbi.nlm.nih.gov/pubmed/30262779 http://dx.doi.org/10.3390/diseases6040088

Ejemplares similares

Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients
por: Feola, Mauro, et al.
Publicado: (2016)

The Analysis of Arterial Stiffness in Heart Failure Patients in Comparison with Healthy Subjects and Patients with Cardiovascular Risk Factors
por: Feola, Mauro, et al.
Publicado: (2019)

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients
por: Leto, Laura, et al.
Publicado: (2015)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

Correction: Feola, M., et al. Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation. J. Clin. Med. 2020, 9, 2932
por: Feola, Mauro, et al.
Publicado: (2021)

The Analysis of Arterial Stiffness in Heart Failure Patients: The Prognostic Role of Pulse Wave Velocity, Augmentation Index and Stiffness Index
por: Anastasio, Fabio, et al.
Publicado: (2022)

Usefulness of a Telemedicine Program in Refractory Older Congestive Heart Failure Patients
por: Burdese, Emanuela, et al.
Publicado: (2018)

Relationship between Cognitive Function, Depression/Anxiety and Functional Parameters in Patients Admitted for Congestive Heart Failure
por: Feola, Mauro, et al.
Publicado: (2013)

Effects of a short-term alirocumab administration on the aortic stiffness: preliminary results
por: Mauro, Feola, et al.
Publicado: (2019)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
por: Yin, Qiu-Sheng, et al.
Publicado: (2014)

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3
por: Stoica, Alexandra, et al.
Publicado: (2018)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

The potential value of integrated natriuretic peptide and echo-guided heart failure management
por: Scali, Maria Chiara, et al.
Publicado: (2014)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensation
por: Feola, Mauro, et al.
Publicado: (2012)

Diagnostic value of brain natriuretic peptide and β-endorphin plasma concentration changes in patients with acute left heart failure and atrial fibrillation
por: Feng, Shao-Dan, et al.
Publicado: (2017)

Diagnostic value of plasma C-type natriuretic peptide levels in determination of the duration of mesenteric ischaemia
por: Demirtas, Sinan, et al.
Publicado: (2014)

The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure
por: Guo, Xuxue, et al.
Publicado: (2018)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

The Diagnostic and Prognostic Value of Plasma Galectin 3 in HFrEF Related to the Etiology of Heart Failure
por: Lu, Qun, et al.
Publicado: (2021)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Atrial Natriuretic Peptide in Young and Elderly Children with Mild Gastroenteritis
por: Klar, A., et al.
Publicado: (2009)

Prognostic Value of Galectin-3 in Patients with Heart Failure
por: Bošnjak, Ivica, et al.
Publicado: (2015)

High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?
por: Yu, Long Hao, et al.
Publicado: (2010)

Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function
por: GONG, HUI, et al.
Publicado: (2014)

N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors
por: Patel, Shruti Rajesh, et al.
Publicado: (2021)

Plasma levels of natriuretic peptides and development of chronic kidney disease
por: Ogawa, Noriyuki, et al.
Publicado: (2015)

Plasma brain natriuretic peptide levels are elevated in patients with cancer
por: Bando, Sachiko, et al.
Publicado: (2017)

Clinical value of combined plasma brain natriuretic peptide and serum cystatin C measurement on the prediction of heart failure in patients after acute myocardial infarction
por: Liu, Rui, et al.
Publicado: (2023)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Role of (123)I-Iobenguane Myocardial Scintigraphy in Predicting Short-term Left Ventricular Functional Recovery: An Interesting Image
por: Feola, Mauro, et al.
Publicado: (2015)

Prognostic value of brain natriuretic peptide in acute pulmonary embolism
por: Coutance, Guillaume, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fdtuigdvgqhl9b848dq2qmaqls